New antibody shows promise in clearing heart clumps in rare disease
NCT ID NCT07448623
First seen Mar 10, 2026 · Last updated Jun 18, 2026 · Updated 19 times
Summary
This early-stage study is for people with a heart condition called ATTR-CM, caused by abnormal protein buildup in the heart. Researchers are testing a new antibody, coramitug, to see how well it targets and helps remove these protein clumps. The study uses special imaging to track the drug in the body and check its safety. About 14 participants aged 60 and older will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRANSTHYRETIN AMYLOID CARDIOMYOPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
ICON - location Groningen
RECRUITINGGroningen, 9728 NZ, Netherlands
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.